MM

Maria Maccecchini

AB Annovis Bio: 8 patents #1 of 1Top 100%
BB Bearsden Bio: 4 patents #1 of 7Top 15%
TR Transgenomic: 3 patents #10 of 46Top 25%
Depuy Synthes Products: 1 patents #1,112 of 1,658Top 70%
IC International Minerals & Chemical: 1 patents #60 of 132Top 50%
SU Synthes Usa: 1 patents #247 of 457Top 55%
Overall (All Time): #202,843 of 4,157,543Top 5%
21
Patents All Time

Issued Patents All Time

Showing 1–21 of 21 patents

Patent #TitleCo-InventorsDate
12390448 Prevention or of disease states due to metal dis-homeostasis via administration of posiphen to healthy or sick humans 2025-08-19
12144798 (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8ahexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration 2024-11-19
12042482 Methods of treatment or prevention of acute brain or nerve injuries 2024-07-23
11596621 Prevention or treatment of disease states due to metal dis-homeostasis via administration of Posiphen to healthy or sick humans 2023-03-07
11400075 (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration 2022-08-02
11382893 (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration 2022-07-12
11376238 (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration 2022-07-05
11096926 (3AR)-1,3A,8-trimethyl-1,2,3,3A,8,8A-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration 2021-08-24
10383851 (3aR)-1,3a,8-Trimethyl-1 ,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration 2019-08-20
9345818 Methods for the in situ treatment of bone cancer 2016-05-24
7914810 Methods for the in situ treatment of bone cancer 2011-03-29
6894048 Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors Xue-Feng Pei, Baoqing Li 2005-05-17
6887867 5H-2,3-benzodiazepine antagonists of excitatory amino acid receptors Xue-Feng Pei, Baoqing Li 2005-05-03
6703390 Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors Xue-Feng Pei, Baoqing Li 2004-03-09
6511963 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function 2003-01-28
6284731 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function 2001-09-04
6110894 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function 2000-08-29
5854217 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function 1998-12-29
5830998 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function 1998-11-03
5523323 Use of partial agonists of the NMDA receptor to reduce opiate induced tolerance and dependence 1996-06-04
4599229 Method of promoting animal growth using antibodies against somatostatin 1986-07-08